Common use of Laboratory Procedures Clause in Contracts

Laboratory Procedures. The laboratory utilized for blood and urine testing will be designated by the Employer after a recommendation of the OPBA prior to March 1, of each calendar year in which testing is to take place. The laboratory must have a current certification that it meets College of American Pathologists’ Forensic Drug Testing Accreditation standards as well as proof that it is operating with Department of Health and Human Services/Substance abuse and Mental Health Services Administration (SAMHSA) certification. Strict chain of custody procedures must be followed for all samples as set by NIDA. The Employer and the OPBA agree that security of submitted biological samples is such a paramount issue that any breach of the chain of custody or apparent tampering with sample integrity results immediately in an invalid sample that may not be used for any purposes. A split sample shall be reserved in all cases for an independent analysis in the event of a positive test result. All samples must be stored in a scientifically acceptable preservation manner as established by NIDA. All positive confirmed samples and related paperwork must be retained by the laboratory for at least one year or for the duration of any grievance, disciplinary action, or legal proceedings regarding the sample, whichever is longer. At the conclusion of said period, the sample is to be destroyed along with laboratory maintained paperwork. The laboratory is authorized to test only for the following drugs or classes of drugs: marijuana metabolites, cocaine metabolites, opiate metabolites, Phencyclidine, and amphetamines. The laboratory shall test only for these substances within the limits of initial and confirmation tests as currently defined by DHHS/SAMHSA. Initial testing will consist of a preliminary immunoassay (EMIT Screen). If initial testing results are negative, testing shall be discontinued. Under this Agreement, the following cutoff levels shall be used in determining test results as positive or negative:

Laboratory Procedures. The laboratory utilized for blood and urine testing will be designated by the Employer after a recommendation of the OPBA Teamster Local 436 prior to March 1, of each calendar year in which testing is to take place. The laboratory must have a current certification that it meets College of American Pathologists’ Forensic c Drug Testing Accreditation standards as well as proof that it is operating with Department of Health and Human Services/Substance abuse and Mental Health Services Administration (SAMHSA) certification. Strict chain of custody procedures must be followed for all samples as set by NIDA. The Employer and the OPBA members of Teamsters Local 436 agree that security of submitted biological samples is such a paramount issue that any breach of the chain of custody or apparent tampering with sample integrity results immediately in an invalid sample that may not be used for any purposes. A split sample shall be reserved in all cases for an independent analysis in the event of a positive test result. All samples must be stored in a scientifically acceptable preservation manner as established by NIDA. All positive confirmed samples and related paperwork must be retained by the laboratory for at least one year or for the duration of any grievance, disciplinary action, or legal proceedings regarding the sample, whichever is longer. At the conclusion of said period, the sample is to be destroyed along with laboratory maintained paperwork. The laboratory is authorized to test only for the following drugs or classes of drugs: marijuana ; Marijuana metabolites, cocaine metabolites, opiate metabolites, Phencyclidine, and amphetamines. The laboratory shall test only for these substances within the limits of initial and confirmation tests as currently defined by DHHS/SAMHSA. Initial testing will consist of a preliminary immunoassay (EMIT Screen). If initial testing results are negative, testing shall be discontinued. If initial testing results are positive, the results shall be confirmed using gas chromatography/mass spectrometry (GS/MS) techniques. Under this Agreement, the following cutoff levels shall be used in determining test results as positive or negative:: Drug Class. Prelim. Cutoff Confirm. Cutoff Marijuana metabolites 100 ng/ml 15 ng/ml Cocaine metabolites 300 ng/ml 150 ng/ml Opiate metabolites 2,000 ng/ml 2,000 ng/ml Phencyclidine 25 ng/ml 25 ng/ml Amphetamines 1,000 ng/ml 500 ng/ml alternative medical explanations, positive results in the case where both the preliminary and confirmatory test results are positive as to the same sample and independent investigation provides no reasonable alternative medical explanation. All initial and confirmatory testing shall be performed at a certified laboratory and not at any individual collection site. In the event that tests are altered, invalid, diluted positive or positive test results, upon request to the MRO, each covered employee will be provided with a report of the confirmed positive results of each test that includes the types of tests conducted, the results of each test, the detection level used by the laboratory and any other information provided to the Employer by the laboratory.

Laboratory Procedures. The laboratory utilized for blood and urine testing will be designated by the Employer after a recommendation of the OPBA Teamster Local 436 prior to March 1, of each calendar year in which testing is to take place. The laboratory must have a current certification that it meets College of American Pathologists’ Forensic Drug certific Testing Accreditation standards as well as proof that it is operating with Department of Health and Human Services/Substance abuse and Mental Health Services Administration (SAMHSA) certification. Strict chain of custody procedures must be followed for all samples as set by NIDA. The Employer and the OPBA members of Teamsters Local 436 agree that security of submitted biological samples is such a paramount issue that any breach of the chain of custody or apparent tampering with sample integrity results immediately in an invalid sample that may not be used for any purposes. A split sample shall be reserved in all cases for an independent analysis in the event of a positive test result. All samples must be stored in a scientifically acceptable preservation manner as established by NIDA. All positive confirmed samples and related paperwork must be retained by the laboratory for at least one year or for the duration of any grievance, disciplinary action, action or legal proceedings regarding the sample, whichever is longer. At the conclusion of said period, the sample is to be destroyed along with laboratory maintained paperwork. The laboratory is authorized to test only for the following drugs or classes of drugs: marijuana metabolites, cocaine metabolites, opiate metabolites, Phencyclidine, Phencyclidine and amphetamines. The laboratory shall test only for these substances within the limits of initial and confirmation tests as currently defined by DHHS/SAMHSA. Initial testing will consist of a preliminary immunoassay (EMIT Screen). If initial testing results are negative, testing shall be discontinued. If initial testing results are positive, the results shall be confirmed using gas chromatography/mass spectrometry (GS/MS) techniques. Under this Agreement, the following cutoff levels shall be used in determining test results as positive or negative:: Drug Class. Prelim. Cutoff Confirm. Cutoff Marijuana metabolites 100 ng/ml 15 ng/ml Cocaine metabolites 300 ng/ml 150 ng/ml Opiate metabolites 2,000 ng/ml 2,000 ng/ml Phencyclidine 25 ng/ml 25 ng/ml Amphetamines 1,000 ng/ml 500 ng/ml alternative medical explanations, positive results in the case where both the preliminary and confirmatory test results are positive as to the same sample and the explanation. All initial and confirmatory testing shall be performed at a certified laboratory and not at any individual collection site. In the event that tests are altered, invalid, diluted positive or positive test results, upon request to the MRO, each covered employee will be provided with a report of the confirmed positive results of each test that includes the types of tests conducted, the results of each test, the detection level used by the laboratory and any other information provided to the Employer by the laboratory.